Sort

Search

01/11/2023 Characterization of add-on testing before and after automation at a core laboratory
García-Osuna, A, Muñoz, LG, Pallaruelo, MC, Usero, AM, Eduardo, BC, Ramos, JL, Canyelles, M, Brú, CM, Cámara, FJI. Characterization of add-on testing before and after automation at a core laboratory. Heliyon. 2023; 9(11)DOI:10.1016/j.heliyon.2023.e22096. PMID:38034602. IF:3.400(Q1/3D).
01/11/2023 Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant
Mehta, G, Riva, A, Ballester, MP, Uson, E, Pujadas, M, Carvalho-Gomes, A, Sahuco, I, Bono, A, D'Amico, F, Viganò, R, Diago, E, Lanseros, BT, Inglese, E, Vazquez, DM, Sharma, R, Tsou, HLP, Harris, N, Broekhoven, A, Kikkert, M, Morales, SPT, Myeni, SK, Riveiro-Barciela, M, Palom, A, Zeni, N, Brocca, A, Cussigh, A, Cmet, S, Escudero-García, D, Stocco, M, Natola, LA, Ieluzzi, D, Paon, V, Sangiovanni, A, Farina, E, di Benedetto, C, Sánchez-Torrijos, Y, Lucena-Varela, A, Román, E, Sánchez, E, Sánchez-Aldehuelo, R, López-Cardona, J, Canas-Perez, I, Eastgate, C, Jeyanesan, D, Morocho, AE, Di Cola, S, Lapenna, L, Zaccherini, G, Bongiovanni, D, Zanaga, P, Sayaf, K, Hossain, S, Crespo, J, Robles-Díaz, M, Madejón, A, Degroote, H, Fernández, J, Korenjak, M, Verhelst, X, García-Samaniego, J, Andrade, RJ, Iruzubieta, P, Wright, G, Caraceni, P, Merli, M, Patel, VC, Gander, A, Albillos, A, Soriano, G, Donato, MF, Sacerdoti, D, Toniutto, P, Buti, M, Duvoux, C, Grossi, PA, Berg, T, Polak, WG, Puoti, M, Bosch-Comas, A, Belli, L, Burra, P, Russo, FP, Coenraad, M, Calleja, JL, Perricone, G, Berenguer, M, Claria, J, Moreau, R, Arroyo, V, Angeli, P, Sánchez, C, Ampuero, J, Piano, S, Chokshi, S, Jalan, R. Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant. Hepatology Communications. 2023; 7(11)DOI:10.1097/HC9.0000000000000273. PMID:37870985. IF:5.600(Q1/2D).
01/11/2023 Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA
Plaza, V, Domínguez-Ortega, J, Alsina, DGS, Lo Re, D, Sicras-Mainar, A. Comprehensive Observational Study in a Large Cohort of Asthma Patients after Adding LAMA to ICS/LABA. Pharmaceuticals. 2023; 16(11)DOI:10.3390/ph16111609. PMID:38004474. IF:4.300(Q1/2D).
01/11/2023 A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes
Santos, JR, Domingo, P, Portilla, J, Gutiérrez, F, Imaz, A, Vilchez, H, Curran, A, Valcarce-Pardeiro, N, Payeras, A, Bernal, E, Montero-Alonso, M, Yzusqui, M, Clotet, B, Videla, S, Moltó, J, Paredes, R. A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes. Open Forum Infectious Diseases. 2023; 10(11)DOI:10.1093/ofid/ofad542. PMID:38023553. IF:3.800(Q2/3D).
01/11/2023 Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer
Nadal E., Oré-Arce M., Remon J., Bernabé-Caro R., Covela-Rúa M., de Castro-Carpeño J., Massutí-Sureda B., Guillot-Morales M., Majem M., Maestu-Maiques I., Morilla-Ruíz I., Gironés R.. Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer. Clinical & Translational Oncology. 2023; 25(11)DOI:10.1007/s12094-023-03286-3. PMID:37566345. IF:2.800(Q2/5D).
01/11/2023 Efficient Delivery of Antimicrobial Peptides in an Innovative, Slow-Release Pharmacological Formulation
Serna, N, López-Laguna, H, Aceituno, P, Rojas-Peña, M, Parladé, E, Voltà-Durán, E, Martínez-Torró, C, Sánchez, JM, Di Somma, A, Carratalá, JV, Livieri, AL, Ferrer-Miralles, N, Vázquez, E, Unzueta, U, Roher, N, Villaverde, A. Efficient Delivery of Antimicrobial Peptides in an Innovative, Slow-Release Pharmacological Formulation. Pharmaceutics. 2023; 15(11)DOI:10.3390/pharmaceutics15112632. PMID:38004610. IF:4.900(Q1/2D).
01/11/2023 Predictive capacity of FAT1 transcriptional expression in patients with head and neck squamous cell carcinomas treated with radiotherapy
León X., Llansana A., Pérez-Ugarte L., García J., Valero C., Quer M., Camacho M.. Predictive capacity of FAT1 transcriptional expression in patients with head and neck squamous cell carcinomas treated with radiotherapy. Acta Otorrinolaringologica Espanola. 2023; 74(6)DOI:10.1016/j.otorri.2023.03.003. PMID:37931687. IF:(Q/D).
01/11/2023 Second esophageal neoplasms after head and neck index tumor: Incidence, risk factors and prognosis
Pujol A., Llansana A., Pérez-Ugarte L., Sauter B., Quer M., León X.. Second esophageal neoplasms after head and neck index tumor: Incidence, risk factors and prognosis. Acta Otorrinolaringologica Espanola. 2023; 74(6)DOI:10.1016/j.otorri.2022.10.005. PMID:. IF:(Q/D).